The Acute Dialysis Quality Initiative--part VI: access and anticoagulation in CRRT.
Both the choice of vascular access and anticoagulant regimen for continuous renal replacement therapy (CRRT) are a major determinant of not only circuit life span but also affect solute clearance. This evidence-based review critically examines the published rature on different vascular access sites, access types, and anticoagulation regimens, to provide clinical guidelines for good working practices and to direct future studies.
Davenport
Andrew
A
Department of Nephrology, Royal Free Hospital, London, United Kingdom. andrew.davenport@rfh.nthames.nhs.uk
Mehta
Sangeeta
S
D000925:Anticoagulants / Q000627:therapeutic use*; D002408:Catheters, Indwelling; D006801:Humans; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care / Q000379:methods*; D006435:Renal Dialysis / Q000592:standards*
D000925:Anticoagulants